Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
